BioSpace News Archive

Topline results from Agios Pharmaceuticals’ Phase III ACTIVATE trial show that treatment with mitapivat was associated with a significantly greater hemoglobin response compared with placebo in patients with pyruvate kinase deficiency.

The FDA uses special designations to get new, breakthrough treatments to patients in the greatest need.

With two COVID-19 vaccines pending eminent FDA review, the biggest hurdle to widespread vaccinations is simply convincing people to be vaccinated.

Junshi Biosciences, an innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, is pleased to announce that the Phase I clinical study of a recombinant humanized anti-TROP2 monoclonal antibody - Tub196 conjugate, has completed the dosing of the first patient.

According to the report, the global tissue processing systems market was valued at US$ 318.5 Mn in 2019 and is projected to expand at a CAGR of ~5% from 2020 to 2030.

According to the report, the global stool secretory immunoglobulin A market was valued at ~US$ 27 Mn in 2019.

Transparency Market Research has published a new report titled, PACS and RIS Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

Dental vacuum pumps are devices used for the suction of residue or fluids resulting from dental surgeries.

Mesotherapy refers to a non-invasive cosmetic treatment option that is gaining traction in major developed as well as developing countries across the globe.

According to the report, the global hydroxychloroquine drugs market was valued at US$ 0.67 Bn in 2019 and is projected to expand at a CAGR of 10% from 2020 to 2030.